- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03620812
Influence of Rapeseed Proteins on the Postprandial Metabolic Response
May 18, 2020 updated by: Ulf Schlegelmilch, Martin-Luther-Universität Halle-Wittenberg
Influence of Rapeseed Proteins on the Postprandial Metabolic Response.
The aim of the study is to investigate the effect of rapeseed proteins on the postprandial metabolic response.
Therefore, study participants will receive a meal rich in fat and carbohydrates with and without rapeseed protein or with soy protein that serves as control.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The current study is a monocentric, controlled intervention study that will be conducted as cross-over design.
Three interventions are planned and participants will be invited to consume a test meal with added rapeseed protein isolate, a test meal with added soy protein isolate and a test meal without additional protein.
The evening before, the subjects will receive a standardized dinner.
After a 12-hour fasting overnight, a cannula will be placed.
Blood samples will be taken before and after eating the test meal rich in carbohydrate and fat.
The test meal consists of pasta with oily tomato sauce with either 25 g of rapeseed protein, 25 g of soy protein or no additional protein.
A total of 11 blood samples will be collected over a period of 6 hours.
In the meantime, the blood pressure and pulse will be measured repeatedly and information on satiety will be recorded.
The interventions will be interrupted by a period of, at least, 2 weeks.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saxony Anhalt
-
Halle, Saxony Anhalt, Germany, 06120
- Martin-Luther-University Institute of Agriculture and Nutritional Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy men and women
- age between 18 and 65 years
- informed consent
- body mass index between 18,5 up to 29,9 kg/m2
- anamnesis without diagnostic findings
Exclusion Criteria:
- acute or chronic diseases ((hypertension, coronary diseases, renal diseases, diabetes, alcohol abuse etc.)
- intake of drugs (exemption: oral contraceptive)
- pregnancy or lactation
- food intolerance or allergies to mustard, soy, tomato, wheat
- participation on another trial
- blood donation - while last 2 month before the start of the study
- extensive physical activity (competitive sports, hard physical work)
- diet procedure
- smoking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: rapeseed protein
Three interventions are planned, in which the subjects will eat a test meal with added rape protein isolate (arm 1), a test meal with added soy protein isolate (arm 2) and a test meal without additional protein (arm 3) in random order on 3 days.
The subjects are randomly assigned to one of the 3 treatment arms, ultimately resulting in 6 sequences (cross-over)
|
25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day
|
Active Comparator: soy protein
|
25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day
|
Placebo Comparator: no protein
|
25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
time course of glucose level
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial blood glucose level
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cholesterol
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of Cholesterol
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
triglycerides
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of triglycerides
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
short chain fatty acids
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of short chain fatty acids
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
indole-3-propionate
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of indole-3-propionate
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
amino acids
Time Frame: 0,15,30,45,60,90,120 and 180 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of amino acids
|
0,15,30,45,60,90,120 and 180 min after ingestion of testmeal rich in carbohydrates and fat
|
hormones (insulin, ghrelin, FGF23)
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of hormones (insulin, ghrelin, FGF23)
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
time course of urea level,
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of urea
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
minerals and blood hsCRP
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Impact of rapeseed protein on the postprandial levels of minerals and blood hsCRP
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
systolic and diastolic blood pressures
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
time course: measurement of blood pressure in mm Hg
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
feeling of satiety by means of a questionnaire
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
|
heart rate
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
time course: measurement of heart rate in beats per minute
|
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Gabriele Stangl, Prof.Dr., MLU, Institut für Agrar-und Ernährungswissenschaften
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 16, 2018
Primary Completion (Actual)
April 6, 2019
Study Completion (Actual)
December 15, 2019
Study Registration Dates
First Submitted
June 26, 2018
First Submitted That Met QC Criteria
August 6, 2018
First Posted (Actual)
August 8, 2018
Study Record Updates
Last Update Posted (Actual)
May 19, 2020
Last Update Submitted That Met QC Criteria
May 18, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- UFOP 062018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health, Subjective
-
Chulalongkorn UniversityNot yet recruiting
-
Prince Sattam Bin Abdulaziz UniversityCompletedHealth, SubjectiveSaudi Arabia
-
Çankırı Karatekin UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCompleted
-
Hebrew SeniorLifeCompletedHealth, Subjective
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingHealth, Subjective
-
Bahçeşehir UniversityNot yet recruiting
-
BMI KoreaCompletedHealth, SubjectiveKorea, Republic of
-
Alteogen, Inc.CompletedHealth, SubjectiveKorea, Republic of
-
Tel Aviv UniversityCompletedHealth, SubjectiveIsrael
Clinical Trials on rapeseed or soy protein or no protein
-
Medical University of ViennaUnknown
-
McMaster UniversityNational Dairy CouncilCompleted
-
University of TorontoHeart and Stroke Foundation of Ontario; Orafti GroupCompletedCardiovascular Disease | Hyperlipidemia | Diet TherapyCanada
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
John SievenpiperNot yet recruitingDyslipidemias | Cardiovascular Risk Factor | DysglycemiaCanada
-
University of ReadingCompletedOlder AdultsUnited Kingdom
-
University of CopenhagenEuropean CommissionCompletedObesity | Cardiovascular Disease | Metabolic Syndrome | Type 2 DiabetesDenmark
-
Tulane UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Hypercholesterolemia
-
Tulane UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | HypertensionUnited States
-
Ohio UniversityRecruitingMetabolismUnited States